Platelets Rich Plasma Increases Antioxidant Defenses of Tenocytes via Nrf2 Signal Pathway.
Nrf2
oxidative stress
platelet-rich plasma
protein oxidation
tendinopathy
tenocytes
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
27 Aug 2023
27 Aug 2023
Historique:
received:
31
07
2023
revised:
21
08
2023
accepted:
23
08
2023
medline:
11
9
2023
pubmed:
9
9
2023
entrez:
9
9
2023
Statut:
epublish
Résumé
Tendinopathies are common disabling conditions in equine and human athletes. The etiology is still unclear, although reactive oxygen species (ROS) and oxidative stress (OS) seem to play a crucial role. In addition, OS has been implicated in the failure of tendon lesion repair. Platelet-rich plasma (PRP) is rich in growth factors that promote tissue regeneration. This is a promising therapeutic approach in tendon injury. Moreover, growing evidence has been attributed to PRP antioxidant effects that can sustain tissue healing. In this study, the potential antioxidant effects of PRP in tenocytes exposed to oxidative stress were investigated. The results demonstrated that PRP reduces protein and lipid oxidative damage and protects tenocytes from OS-induced cell death. The results also showed that PRP was able to increase nuclear levels of redox-dependent transcription factor Nrf2 and to induce some antioxidant/phase II detoxifying enzymes (superoxide dismutase 2, catalase, heme oxygenase 1, NAD(P)H oxidoreductase quinone-1, glutamate cysteine ligase catalytic subunit and glutathione, S-transferase). Moreover, PRP also increased the enzymatic activity of catalase and glutathione S-transferase. In conclusion, this study suggests that PRP could activate various cellular signaling pathways, including the Nrf2 pathway, for the restoration of tenocyte homeostasis and to promote tendon regeneration and repair following tendon injuries.
Identifiants
pubmed: 37686103
pii: ijms241713299
doi: 10.3390/ijms241713299
pmc: PMC10488198
pii:
doi:
Substances chimiques
Antioxidants
0
Catalase
EC 1.11.1.6
NF-E2-Related Factor 2
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : University of Perugia, Grant: "FONDO D'ATENEO PER LA RICERCA DI BASE 2017-2019"
ID : RICERCA DI BASE 2017-2019
Références
J Pediatr Urol. 2017 Jun;13(3):317.e1-317.e9
pubmed: 28215833
J Am Chem Soc. 2011 Sep 7;133(35):14109-19
pubmed: 21786801
Oxid Med Cell Longev. 2020 Nov 23;2020:4127959
pubmed: 33299525
Br J Sports Med. 2004 Dec;38(6):672-4
pubmed: 15562157
Adv Exp Med Biol. 2016;920:11-25
pubmed: 27535245
Oxid Med Cell Longev. 2019 Dec 2;2019:7591840
pubmed: 31885814
Exp Eye Res. 2022 Jul;220:109100
pubmed: 35504323
J Shoulder Elbow Surg. 2012 Feb;21(2):218-27
pubmed: 22244065
J Orthop Res. 2018 Dec;36(12):3268-3274
pubmed: 30066401
Drug Des Devel Ther. 2018 Mar 20;12:591-603
pubmed: 29593382
Cell Death Dis. 2020 Sep 17;11(9):772
pubmed: 32943614
Am J Sports Med. 2007 Feb;35(2):245-51
pubmed: 17099241
J Bone Joint Surg Am. 2013 Apr 3;95(7):e41
pubmed: 23553304
J Drug Target. 2020 Feb;28(2):212-224
pubmed: 31339382
Folia Morphol (Warsz). 2022;81(3):663-678
pubmed: 34018173
Biomed Res Int. 2016;2016:9103792
pubmed: 27610386
Arthroscopy. 2012 Jul;28(7):998-1009
pubmed: 22738751
Knee Surg Sports Traumatol Arthrosc. 2018 Jul;26(7):1984-1999
pubmed: 27665095
Ther Adv Chronic Dis. 2021 Mar 17;12:2040622320987057
pubmed: 33796243
Ann Rheum Dis. 2012 Feb;71(2):302-10
pubmed: 21972243
Platelets. 2016 Dec;27(8):784-790
pubmed: 27255146
Ann N Y Acad Sci. 2021 Apr;1490(1):29-41
pubmed: 33843069
Platelets. 2021 Feb 17;32(2):189-199
pubmed: 33251921
Am J Sports Med. 2016 Aug;44(8):1931-40
pubmed: 27400714
Life Sci. 2020 Feb 15;243:117244
pubmed: 31891721
Histol Histopathol. 2011 Sep;26(9):1173-85
pubmed: 21751149
J Orthop Res. 2021 Aug;39(8):1596-1602
pubmed: 33713481
Eur J Cell Biol. 2023 Mar;102(1):151285
pubmed: 36584599
Stem Cells Int. 2012;2012:374676
pubmed: 22242032
Andrology. 2020 Jan;8(1):191-200
pubmed: 31079423
Biochim Biophys Acta. 2004 Jul 23;1693(1):37-45
pubmed: 15276323
Disabil Rehabil. 2008;30(20-22):1563-71
pubmed: 19005916
J Bone Joint Surg Am. 2021 Jan 20;103(2):174-183
pubmed: 32941310
Int J Mol Med. 2019 Jan;43(1):3-14
pubmed: 30387824
Int J Mol Sci. 2022 Mar 25;23(7):
pubmed: 35408931
J Orthop Res. 2015 Jun;33(6):780-4
pubmed: 25764524
Ann Anat. 2020 May;229:151461
pubmed: 31978571
Am J Sports Med. 2023 May;51(6):1596-1607
pubmed: 37017249
Am J Sports Med. 2013 Jan;41(1):186-93
pubmed: 23211708
J Biol Chem. 2018 Apr 20;293(16):5766-5780
pubmed: 29507095
Foot Ankle Surg. 2020 Apr;26(3):240-249
pubmed: 31031150
Acta Vet Scand. 2018 Oct 26;60(1):63
pubmed: 30367652
Cell Tissue Res. 2015 Feb;359(2):577-587
pubmed: 25358401
Wiley Interdiscip Rev Dev Biol. 2016 Jan-Feb;5(1):5-23
pubmed: 26256998
Front Vet Sci. 2022 Feb 18;9:843131
pubmed: 35252428
J Cell Biochem. 2019 Feb;120(2):1610-1619
pubmed: 30367509
Vet Clin North Am Equine Pract. 2018 Aug;34(2):359-373
pubmed: 29803299
Antioxidants (Basel). 2020 Jun 26;9(6):
pubmed: 32604944
Mol Cell Biol. 2005 Jan;25(2):699-705
pubmed: 15632070
J Cosmet Dermatol. 2023 Apr;22(4):1327-1333
pubmed: 36575876
Calcif Tissue Int. 2019 Oct;105(4):341-352
pubmed: 31236620
Int J Mol Sci. 2020 Oct 21;21(20):
pubmed: 33096812
Nat Rev Dis Primers. 2021 Jan 7;7(1):1
pubmed: 33414454
Histochem Cell Biol. 2011 May;135(5):453-60
pubmed: 21476078
Antioxidants (Basel). 2022 Nov 27;11(12):
pubmed: 36552553
Oxid Med Cell Longev. 2014;2014:360438
pubmed: 24999379
J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Apr 15;1019:178-90
pubmed: 26706659
BMC Sports Sci Med Rehabil. 2022 Jan 6;14(1):5
pubmed: 34991697
Biosci Biotechnol Biochem. 2021 Jun 24;85(7):1686-1696
pubmed: 33974003
Sci Rep. 2019 Feb 26;9(1):2755
pubmed: 30808942
Evid Based Complement Alternat Med. 2021 Jan 18;2021:6692432
pubmed: 33531920
Med Res Rev. 2023 Jan;43(1):237-287
pubmed: 36086898
Rev Bras Ortop (Sao Paulo). 2021 Aug;56(4):432-437
pubmed: 34483385
Int J Mol Sci. 2020 Feb 04;21(3):
pubmed: 32033116